Capital Group Private Markets logo

Capital Group Private Markets

Asia, Beijing, China, Beijing

Description

Capital Group Private Markets is an experienced emerging markets private equity group and part of the capital group companies.

Investor Profile

Capital Group Private Markets has made 2 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series E (50%)
  • Series C (50%)

Country Focus

  • China (50%)
  • United States (50%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Manufacturing
  • Beauty
  • Cosmetics
  • Health Care
  • Internet
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Capital Group Private Markets frequently co-invest with?

CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Curious Office Partners
North America, Washington, United States, Seattle
Co-Investments: 1
Legend Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Ally Bridge Group
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Taikang Insurance Group
Asia, Beijing, China, Beijing
Co-Investments: 1
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 1
Castor Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 1
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1

Which angels does Capital Group Private Markets often collaborate with?

RB
Europe, England, United Kingdom, London
Shared Deals: 1
MJ
North America, California, United States, San Diego
Shared Deals: 1
BH
North America, Washington, United States, Seattle
Shared Deals: 1

What are some of recent deals done by Capital Group Private Markets?

RealSelf

Seattle, Washington, United States

RealSelf is an online community where people can ask questions, share experiences and connect with doctors providing cosmetic treatments.

BeautyCosmeticsHealth CareInternet
Series CAug 10, 2018
Innovent Biologics

Suzhou, Jiangsu, China

Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.

BiopharmaBiotechnologyManufacturing
Series EApr 27, 2018
Amount Raised: $150,000,000